Source: Michael King, JP Morgan (9/5/13)
Analyst Explains Why This Stock Could Go Ballistic
Source: Streetwise Reports (11/21/2017)
read more >
Potential Alzheimer's Therapies Focus on Early Intervention
Source: Streetwise Reports (11/30/2017)
Analysts Say Medical Device Firm Sees Record Quarterly Revenue Growth, 120% YOY
Source: Streetwise Reports (11/29/2017)
Analyst's 'Top Pick' Advances Vaccine Candidates
'Hot' Alzheimer's Market is Promising for Biotech with 'Novel' Drug Candidate
Source: Streetwise Reports (11/20/2017)
Maxim's Target Price on Biotech Makes It More Than a Tenbagger
Stock Price Jump Reflects Biotech's Active October
Biotech Targets 'Blockbuster' Markets; Less-Addictive Opioid Painkiller Set for FDA Filing
Source: John McCamant for Streetwise Reports (11/15/2017)
Biotech's Target Price Increased as Shares 'Deeply Undervalued'
Source: Streetwise Reports (11/15/2017)
Biotech with Solid Pipeline and 'Solid Partnership Outlook'
Source: Streetwise Reports (11/13/2017)
© 2017 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.